Biogened Gelecekteki Büyüme
Future kriter kontrolleri 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Biogened.
Anahtar bilgiler
n/a
Kazanç büyüme oranı
n/a
EPS büyüme oranı
| Pharmaceuticals kazanç büyümesi | 15.4% |
| Gelir büyüme oranı | n/a |
| Gelecekteki özkaynak getirisi | n/a |
| Analist kapsamı | None |
| Son güncelleme | n/a |
Gelecekteki son büyüme güncellemeleri
Güncelleme yok
Recent updates
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb
Aug 28
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)
Aug 22Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding
May 23Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden
May 09Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations
Feb 21Is Biogened (WSE:BGD) A Risky Investment?
Feb 01Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump
Feb 01We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt
Jun 30Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Oct 08Is Biogened (WSE:BGD) A Risky Investment?
Jun 29Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?
Mar 25These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well
Dec 09Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet
Jul 29Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Apr 30Is Biogened (WSE:BGD) A Risky Investment?
Jan 24Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Biogened yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.
SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.
Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 6/30/2024 | 106 | 5 | 4 | 12 | N/A |
| 3/31/2024 | 100 | 4 | 3 | 11 | N/A |
| 12/31/2023 | 96 | 5 | 8 | 15 | N/A |
| 9/30/2023 | 92 | 4 | 7 | 17 | N/A |
| 6/30/2023 | 90 | 4 | -2 | 9 | N/A |
| 3/31/2023 | 85 | 4 | -3 | 6 | N/A |
| 12/31/2022 | 80 | 3 | -3 | 6 | N/A |
| 9/30/2022 | 77 | 4 | -5 | -1 | N/A |
| 6/30/2022 | 72 | 4 | 0 | 2 | N/A |
| 3/31/2022 | 70 | 3 | 4 | 8 | N/A |
| 12/31/2021 | 65 | 2 | 2 | 3 | N/A |
| 9/30/2021 | 57 | 2 | 3 | 7 | N/A |
| 6/30/2021 | 54 | 2 | 4 | 7 | N/A |
| 3/31/2021 | 50 | 1 | 6 | 7 | N/A |
| 12/31/2020 | 48 | 1 | 7 | 9 | N/A |
| 9/30/2020 | 49 | 2 | 6 | 9 | N/A |
| 6/30/2020 | 48 | 1 | 5 | 8 | N/A |
| 3/31/2020 | 48 | 1 | 2 | 7 | N/A |
| 12/31/2019 | 47 | 1 | 2 | 6 | N/A |
| 9/30/2019 | 45 | 1 | -2 | 5 | N/A |
| 6/30/2019 | 44 | 1 | -2 | 4 | N/A |
| 3/31/2019 | 41 | 1 | -1 | 3 | N/A |
| 12/31/2018 | 40 | 1 | -1 | 4 | N/A |
| 9/30/2018 | 39 | 1 | 2 | 6 | N/A |
| 6/30/2018 | 39 | 1 | 0 | 4 | N/A |
| 3/31/2018 | 36 | 1 | N/A | 6 | N/A |
| 12/31/2017 | 34 | 1 | N/A | 6 | N/A |
| 9/30/2017 | 30 | 1 | N/A | 3 | N/A |
| 6/30/2017 | 31 | 1 | N/A | 4 | N/A |
| 3/31/2017 | 29 | 1 | N/A | 0 | N/A |
| 12/31/2016 | 29 | 1 | N/A | -1 | N/A |
| 9/30/2016 | 32 | 2 | N/A | -4 | N/A |
| 6/30/2016 | 31 | 2 | N/A | -5 | N/A |
| 3/31/2016 | 31 | 3 | N/A | -4 | N/A |
| 12/31/2015 | 30 | 3 | N/A | 0 | N/A |
| 9/30/2015 | 30 | 2 | N/A | 1 | N/A |
| 6/30/2015 | 26 | 1 | N/A | 2 | N/A |
| 3/31/2015 | 24 | 1 | N/A | 4 | N/A |
| 12/31/2014 | 23 | 1 | N/A | 1 | N/A |
| 9/30/2014 | 20 | 1 | N/A | 0 | N/A |
| 6/30/2014 | 21 | 1 | N/A | -2 | N/A |
| 3/31/2014 | 22 | 1 | N/A | -4 | N/A |
| 12/31/2013 | 22 | 2 | N/A | -4 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: Insufficient data to determine if BGD's forecast earnings growth is above the savings rate (3.9%).
Kazançlar ve Piyasa: Insufficient data to determine if BGD's earnings are forecast to grow faster than the Polish market
Yüksek Büyüme Kazançları: Insufficient data to determine if BGD's earnings are expected to grow significantly over the next 3 years.
Gelir ve Pazar: Insufficient data to determine if BGD's revenue is forecast to grow faster than the Polish market.
Yüksek Büyüme Geliri: Insufficient data to determine if BGD's revenue is forecast to grow faster than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if BGD's Return on Equity is forecast to be high in 3 years time